Speaker illustration

Mr David Fueller

Emory Clinical Cardiovascular Research Institute, Atlanta (United States of America)

Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease

Event: ESC Congress 2023

Topic: Inflammation and Immunity

Session: Preclinical and clinical laboratory markers in chronic coronary syndromes

Thumbnail

ESC 365 is supported by